• Assesses the impact of spasticity on daily life in people with SCI.
  • Requires participants to recall their past 7 days when rating spasticity on a scale ranging from -3 (extremely problematic) to +3 (extremely helpful).

Clinical Considerations

  • The SCI-SET can be used as a tool for medical management decisions as well as a measurement of current treatment effects.
  • Spasticity is known to be highly variable, fluctuating on a daily and even hourly basis. A seven day recall of the impact of spasticity may be overshadowed by current levels of spasticity. Repeated administration may therefore be necessary to provide a more accurate picture of the impacts spasticity has on daily life.
  • The SCI-SET was developed specifically for the SCI population.
  • The scale is easy to administer and score. Definitions of ‘spasm’ and the scale responses are clearly outlined in the instructions.

ICF Domain

Body Function ▶ Neuromusculoskeletal & Movement-related Functions and Structures


  • Self-report questionnaire.
  • Can be administered in person or over the phone.

Number of Items





Total score (-3 to +3) is generated by summing all the responses from the applicable items then dividing the sum by the number of applicable items.



Training Required

No advanced training required.


Can be found here.

# of studies reporting psychometric properties: 4


  • No meaningful cut points or norms have been established for the SCI population
  • Published data is available for comparison (see Interpretability section of the Research Summary sheet).

MCID: not established in SCI.
SEM: 0.17-0.30
MDC: 0.47-0.82

(Adams et al. 2007; Ansari et al. 2017)


  • The SCI-SET was administered 3 times, 3 weeks in a row, on the same day of the week.
  • Internal consistency of the SCI-SET is high (Cronbach’s a = 0.862-0.95), as is the test-retest reliability (ICC = 0.80-0.91).
  • There is moderate to high test-retest reliability for transfer-related variables (rho = 0.656-0.846).

(Adams et al. 2007; Akpinar et al. 2017; Ansari et al. 2017; Tibbett et al. 2019)


  • The SCI-SET score has high positive and negative correlations between SCI-SET scores and Self-assessment of Spasticity Impact (r = -0.61), Quality of Life Index health and functioning subscale (r = 0.68), and the Penn Spasm Frequency Scale (r = -0.66).
  • The SCI-SET score has moderate positive and negative correlations between SCI-SET scores and Self-assessment of spasticity severity (r = -0.41), self-assessment of spasticity impact (r = -0.47), Self-assessment of Spasticity Severity (r = -0.48).
  • The SCI-SET score has low correlation to the Functional Independence Measure- motor score and PFIM-cognitive subscale (p = 0.13 = 0.21).

(Adams et al. 2007; Akpinar et al. 2017; Ansari et al. 2017)


No values were reported for the responsiveness of the SCI-SCS for the SCI population.

Floor/Ceiling Effect

No values were reported for the presence of floor/ceiling effects in the SCI-SET for the SCI population.


Dr. Vanessa Noonan, Matthew Querée, John Zhu, Risa Fox

Date Last Updated

3 August 2020

Adams M, Martin Ginis K, Hicks A. The Spinal Cord Injury Spasticity Evaluation Tool: Development and Evaluation. Arch Phys Med Rehabil. 2007;88:1185-1192.

Akpinar P, Atici A, Kurt KN, Ozkan FU, Aktas I, Kulcu DG. Reliability and cross-cultural adaptation of the Turkish version of the Spinal Cord Injury Spasticity Evaluation Tool. International Journal of Rehabilitation Research 2017, 40:152–157

Ansari, NN, Kashi M, Naghdi S. The Spinal Cord Injury Spasticity Evaluation Tool: A Persian adaptation and validation study. The Journal of Spinal Cord Medicine 2017, 40 (4).

Tibbet J, Widerström-Noga EG, Thomas CK, Field-Fote EC. Impact of spasticity on transfers and activities of daily living in individuals with spinal cord injury. The Journal of Spinal Cord Medicine. 2019 42:3, 318-327